Cargando…
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic
OBJECTIVES: During the coronavirus disease 2019 (COVID-19) pandemic, public debates overtly addressed the promises of new innovative drugs. Many of these debates pitted those who advocated for the development of new drugs by pharmaceutical companies against those who favored the repositioning of exi...
Autores principales: | Schultz, Émilien, Mignot, Léo, Ward, Jeremy K., Boaventura Bomfim, Daniela, Chabannon, Christian, Mancini, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077798/ https://www.ncbi.nlm.nih.gov/pubmed/35599194 http://dx.doi.org/10.1016/j.therap.2022.05.001 |
Ejemplares similares
-
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021
por: Schultz, Émilien, et al.
Publicado: (2022) -
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
por: Létinier, Louis, et al.
Publicado: (2019) -
French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic
por: Schultz, Émilien, et al.
Publicado: (2021) -
Drug-Induced Kounis Syndrome: Latest Novelties
por: Ollo-Morales, Paula, et al.
Publicado: (2023) -
The Exploitation of Liposomes in the Inhibition of Autophagy to Defeat Drug Resistance
por: Condello, Maria, et al.
Publicado: (2020)